Regulation of neutrophil function by ROS-induced actin glutathionylation
Regulation of neutrophil function by ROS-induced actin glutathionylation
批准号:
8629271
负责人:
Hongbo R Luo
金额:
$43.85万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-03-01 至 2019-02-28
关键词:
ActinsAcute Lung InjuryAddressAdhesionsAffectAsthmaAttenuatedAutomobile DrivingBacterial PneumoniaBiologicalBloodCell AdhesionCell physiologyCellsChemotactic FactorsChemotaxisComplexCysteineDataDiseaseDominant-Negative MutationEnzymesEscherichia coliF-ActinG ActinG-substrateGlutathioneGoalsGrx1 proteinHematopoietic stem cellsHost DefenseInfectionInflammationInflammatoryInvadedKnowledgeLocationLung InflammationLymphocyteMediatingModelingMolecularMultiple SclerosisMusNADPH OxidaseNatural ImmunityNatureNeutrophil InfiltrationPathway interactionsPeritonitisPhagocytesPhagocytosisPhysiologicalPlayPneumoniaPolymersPost-Translational Protein ProcessingProcessProtein SProteinsReactive Oxygen SpeciesRegulationReportingRheumatoid ArthritisRoleSignal TransductionSiteStimulusTestingTissuesbactericidecell typecremaster muscledepolymerizationdisulfide bondeffective therapyglobular proteinin vivointravital microscopykillingsleukemiamacrophagemigrationmutantneutrophilnew therapeutic targetnoveloverexpressionpathogenpublic health relevanceresearch studyresponsetrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Post-translational modification is a fundamental biological regulatory mechanism that controls the location and activity of a wide range of proteins. The goal of this proposed study is to elucidate the role of reactive oxygen species (ROS)-induced actin glutathionylation in controlling actin dynamics in neutrophils. In response to inflammatory stimuli, neutrophils migrate from the circulating blood to infected tissues, where they protect their host by phagocytosing, killing, and digesting bacterial and fungal pathogens. The regulation of actin dynamics is pivotal for cellular processes such as cell adhesion, migration, and phagocytosis and thus is crucial for neutrophils to fulfill their roles in innate immunity. Many factors have been implicated in signal-induced actin polymerization, but the essential nature of the potential negative modulators is still poorly understood. We recently reported that NADPH oxidase-dependent physiologically generated ROS negatively regulate actin polymerization in stimulated neutrophils via driving reversible actin glutathionylation. Protein glutathionylation is a dynamic process and the deglutathionylation is tightly regulated by glutaredoxin 1 (Grx1). Reducing actin glutathionylation by over-expressing Grx1 increased F-actin level, while elevating actin glutathionylation by disrupting Grx1 decreased F-actin level. Consistently, disruption of Grx1 impaired neutrophil chemotaxis. Moreover, Grx1-deficient murine neutrophils showed impaired in vivo recruitment to sites of inflammation and reduced bactericidal capability. Together, these results present a novel physiological role for glutaredoxi and ROS-induced reversible actin glutathionylation in regulation of actin dynamics in neutrophils, leading us to hypothesize that ROS-induced actin glutathionylation is a key regulatory mechanism that controls neutrophil function in innate immunity. Our previous study demonstrates that actin glutathionylation plays a critical role and needs to be well regulated in neutrophil chemotaxis. To further understand the role of ROS-induced actin glutathionylation in neutrophil recruitment and function during infection and inflammation, we will continue to elucidate the contribution of Grx1 and actin glutathionylation in regulating actin dynamics in cellular processes other than chemotaxis, including adhesion, phagocytosis, bacterial killing, turning, and signal transduction (Aim I). Moreover, the role of Grx1 in regulating neutrophil trafficking in vivo will be investigated in a murine cremaster muscle model using intravital microscopy (Aim II). Finally. we will directly elucidate the role of Grx1 in innate immunity and host defense in a murine Escherichia coli pneumonia model (Aim III).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Strategies to Improve Blood Transfusion Practice
-
批准号:10494380
-
项目类别:
-
资助金额:$265.54万
-
财政年份:2022
-
负责人:Hongbo R Luo
-
依托单位:
Novel Strategies to Improve Blood Transfusion Practice
-
批准号:10682582
-
项目类别:
-
资助金额:$259.02万
-
财政年份:2022
-
负责人:Hongbo R Luo
-
依托单位:
Improving granulocyte transfusion in neutropenia-related infections
-
批准号:10494384
-
项目类别:
-
资助金额:$68.15万
-
财政年份:2022
-
负责人:Hongbo R Luo
-
依托单位:
Administrative Core
-
批准号:10494381
-
项目类别:
-
资助金额:$13.22万
-
财政年份:2022
-
负责人:Hongbo R Luo
-
依托单位:
Administrative Core
-
批准号:10682583
-
项目类别:
-
资助金额:$13.22万
-
财政年份:2022
-
负责人:Hongbo R Luo
-
依托单位:
Improving granulocyte transfusion in neutropenia-related infections
-
批准号:10682602
-
项目类别:
-
资助金额:$66.47万
-
财政年份:2022
-
负责人:Hongbo R Luo
-
依托单位:
Regulation of neutrophil death by GSDMD in Candida albicans infection
-
批准号:10229487
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2019
-
负责人:Hongbo R Luo
-
依托单位:
Regulation of neutrophil death by GSDMD in Candida albicans infection
-
批准号:10687091
-
项目类别:
-
资助金额:$30.87万
-
财政年份:2019
-
负责人:Hongbo R Luo
-
依托单位:
Regulation of neutrophil death by GSDMD in Candida albicans infection
-
批准号:9894354
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2019
-
负责人:Hongbo R Luo
-
依托单位:
Regulation of IL-1β bioactivity by Cysteine S-glutathionylation
-
批准号:10405596
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2019
-
负责人:Hongbo R Luo
-
依托单位:
Regulation of IL-1β bioactivity by Cysteine S-glutathionylation
-
批准号:10620756
-
项目类别:
-
资助金额:$16.53万
-
财政年份:2019
-
负责人:Hongbo R Luo
-
依托单位:
Regulation of IL-1β bioactivity by Cysteine S-glutathionylation
-
批准号:10194356
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2019
-
负责人:Hongbo R Luo
-
依托单位:
Regulation of neutrophil death by GSDMD in Candida albicans infection
-
批准号:10460992
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2019
-
负责人:Hongbo R Luo
-
依托单位:
Regulation of neutrophil death by GSDMD in Candida albicans infection
-
批准号:10021397
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2019
-
负责人:Hongbo R Luo
-
依托单位:
Cell-based high-throughput chemical genetic screening for GSDMD inhibitors
-
批准号:10317059
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2019
-
负责人:Hongbo R Luo
-
依托单位:
Regulation of neutrophil function by ROS-induced actin glutathionylation
-
批准号:8811096
-
项目类别:
-
资助金额:$44.1万
-
财政年份:2014
-
负责人:Hongbo R Luo
-
依托单位:
Regulation of neutrophil function by ROS-induced actin glutathionylation
-
批准号:9014505
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2014
-
负责人:Hongbo R Luo
-
依托单位:
Cell signaling in granulocyte transfusion
-
批准号:9294152
-
项目类别:
-
资助金额:$44.57万
-
财政年份:2010
-
负责人:Hongbo R Luo
-
依托单位:
Cell signaling in granulocyte transfusion
-
批准号:7798884
-
项目类别:
-
资助金额:$41.1万
-
财政年份:2009
-
负责人:Hongbo R Luo
-
依托单位:
Enhancing neutrophil function in neutropenia-related pneumonia
-
批准号:7728468
-
项目类别:
-
资助金额:$42.67万
-
财政年份:2009
-
负责人:Hongbo R Luo
-
依托单位:
海外基金